🔴 Ocumetics Technology is trading 5.8% down; no confirmed catalyst identified

Ocumetics Technology is trading 5.8% down at CA$0.41, with the reason for the decline unclear.

• No company announcement dated October 1, 2026, or confirmed company-specific catalyst was identified.
• A September 17 clinical update said Group One patients reached their 12-month follow-up milestone; results were expected shortly, but this does not establish the cause.
• Healthcare was down 1.33%, while broader indices were mixed; the evidence does not clearly explain the stock’s decline.